Chemical formula: C₁₁H₁₃BrN₂O₅ Molecular mass: 333.135 g/mol PubChem compound: 446727
Brivudine interacts in the following cases:
Post-marketing experience indicates a possible interaction of brivudin with anti-Parkinson dopaminergic drugs, that may facilitate the onset of chorea (abnormal, involuntary, dance-like movements, especially of arms, legs and face).
Bribudin should be used with caution in patients with chronic liver disease, such as hepatitis. Post-marketing evidence suggests that extending treatment beyond the recommended 7-day duration increases the risk of developing hepatitis.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
